Drug intelligence / Profile preview

morphine + ibuprofen

Development stage
Unknown
Lead developer
Boots
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Intravenous, Rectal, Intramuscular, Subcutaneous, Intrathecal
01

Overview

Morphine + ibuprofen is a combination of two active pharmaceutical ingredients used together for the management of moderate to severe pain. Morphine is an opioid analgesic that acts primarily as an agonist at mu-opioid receptors in the central nervous system, leading to inhibition of nociceptive (pain) signaling and modulation of pain perception. Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing prostaglandin synthesis, which results in decreased inflammation, pain, and fever. The combination aims to provide enhanced analgesia through complementary mechanisms—opioid receptor agonism and peripheral anti-inflammatory action—potentially allowing for lower doses of each component compared to monotherapy. This can improve pain control while potentially reducing opioid requirements and associated side effects[4][8].

02

Targets

DOR (Opioid Receptor Delta 1)KOR (Kappa opioid receptor)PGHS-1 (Prostaglandin G/H Synthase 1)MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on morphine + ibuprofen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morphine + ibuprofen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call